Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc. is not a good value stock. Milestone Pharmaceuticals Inc. is not very popular among insiders. Milestone Pharmaceuticals Inc. is a mediocre stock to choose.

News

Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China

Globe Newswire MONTREAL and CHARLOTTE, N.C., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...\n more…

Milestone Pharmaceuticals appoints Joseph Papa to board of directors

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Milestone Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire MONTREAL and CHARLOTTE, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will participate in the H.C...\n more…

Milestone Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

Globe Newswire MONTREAL and CHARLOTTE, N.C., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...\n more…

HC Wainwright Analysts Lower Earnings Estimates for Milestone Pharmaceuticals Inc. (NASDAQ:MIST)

Ticker Report Milestone Pharmaceuticals Inc. (NASDAQ:MIST - Free Report) - Investment analysts at HC Wainwright reduced their FY2024 earnings per share (EPS) estimates for shares of Milestone Pharmaceuticals in a...\n more…